For a medication that depends on cold-chain timing and on someone being available to receive it, multi-channel tracking is best
Administration method: Subcutaneous injection, once a day, for 8 consecutive weeks
Then units = (dose concentration) 100
Most treatment struggles with CIP because it is fragmented
Growth Hormone Secretagogues Growth hormone secretagogues (GHS) are a class of compounds that have become a hot topic in research regarding their role in stimulating the release of growth hormone (GH) from the pituitary gland
A total of 577 patients were randomly assigned (1:1:1) to receive once-weekly dulaglutide (1.5 mg), once-weekly dulaglutide (0.75 mg), or daily insulin glargine as basal therapy, all in combination with insulin lispro, for 52 weeks